Vioxx

/Tag:Vioxx

Transvaginal Mesh Settlement Talks May be Underway

US District Court, Charleston WV Although unsubstantiated at this time, C.R. Bard and the makers of transvaginal mesh are said to be in settlement talks with lawyers representing 50,000 plaintiffs. This according to Bloomberg but not confirmed by any of the companies involved. The last two lawsuits naming Read more

By | 2013-09-30T14:56:14+00:00 September 30th, 2013|Legal News|6 Comments

Welcome to MDND

June 1, 2013 ~ Welcome.  I’m Jane Akre, the Editor of MDND. We are now entering our second year of publishing and unfortunately the mesh-injured community is only growing.  At last count there were nearly 22,000 cases consolidated in one federal court in West Virginia and that does not take Read more

By | 2013-05-30T11:45:59+00:00 May 30th, 2013|Welcome|1 Comment

Question: Which Transvaginal Mesh Trials are Next?

MDND (Mesh Medical Device News Desk) and its FB Page have been receiving a lot of questions about which trials are scheduled to follow Linda Gross v. Ethicon, which on Thursday, February 28 resulted in an $11.1 million award to Linda and Jeff Gross. The award includes $7.76 million in Read more

By | 2013-02-20T13:07:59+00:00 February 20th, 2013|Your Turn|21 Comments

Lead Attorneys to be Chosen in Transvaginal Mesh Cases Friday, April 13

The Honorable Judge Joseph Goodwin The Honorable Judge Joseph Goodwin will oversee a hearing Friday, April 13, to decide who will be the lead attorneys in the consolidated lawsuits over defective transvaginal mesh. Hundreds of cases have been consolidated in the Southern District of West Virginia in Multidistrict Read more

By | 2012-04-12T23:44:20+00:00 April 12th, 2012|Legal News|2 Comments

Merck’s Blockbuster Vioxx Settlement

NOVEMBER 22, 2011-When a defective product has harmed so many people and cost so many lives, the settlement numbers are huge too. Now the U.S. Justice Department says it has settled its civil case with Merck, the pharmaceutical giant that aggressively marketed Vioxx (Rofecoxib) making it a blockbuster Read more

By | 2011-11-23T04:57:05+00:00 November 23rd, 2011|Media Reports|0 Comments